Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer

被引:87
作者
Humar, B
Graziano, F
Cascinu, S
Catalano, V
Ruzzo, AM
Magnani, M
Toro, T
Burchill, T
Futschik, ME
Merriman, T
Guilford, P
机构
[1] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, Aotearoa, New Zealand
[2] Hosp Urbino, Div Med Oncol, I-61029 Urbino, Italy
[3] Hosp Parma, I-43100 Parma, Italy
[4] Hosp Pesaro, I-61100 Pesaro, Italy
[5] Univ Urbino, G Fornaini Inst Biochem & Mol Biol, I-61029 Urbino, Italy
[6] Univ Otago, Knowledge Engn Lab, Dunedin, Aotearoa, New Zealand
[7] Univ Otago, Biochem Lab, Dunedin, Aotearoa, New Zealand
关键词
diffuse gastric cancer; E-cadherin; CDH1; polymorphism; genetics;
D O I
10.1038/sj.onc.1205921
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Truncating mutations in the gene for the cell to cell adhesion protein E-cadherin are the most consistent genetic alterations observed in sporadic and hereditary diffuse gastric cancer (DGC). In addition to these inactivating mutations, a CDH1 promoter polymorphism at position -160 has been reported to lead to transcriptional downregulation of the gene in vitro. We therefore performed a case-control study to investigate whether this variant is associated with an increased susceptibility to DGC. The frequency of the - 160A allele was significantly higher (P < 0.005) in 53 diffuse gastric cancer cases compared to 70 matched controls. The odds ratio associated with the A-allele was 2.27 for CA-heterozygotes (95% CI 1.16-4.44) and 7.84 for AA-homozygotes (95% CI 2.89-21.24). Two additional polymorphisms (the 48+6T-->C and the 2076C-->T variant) were genotyped and shown to be equally distributed among cases and controls. Haplotype analysis with the three polymorphisms confirmed an association with disease (P < 0.004). However, this analysis suggested the -160C --> A CDH1 promoter polymorphism may be in linkage disequilibrium with a distinct aetiological locus or acts in combination with other functional variants in or near the C-DH1 region.
引用
收藏
页码:8192 / 8195
页数:4
相关论文
共 21 条
[1]   E-cadherin is not frequently mutated in hereditary gastric cancer [J].
Avizienyte, E ;
Launonen, V ;
Salovaara, R ;
Kiviluoto, T ;
Aaltonen, LA .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (01) :49-52
[2]  
Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO
[3]  
2-D
[4]   Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma [J].
Borch, K ;
Jönsson, B ;
Tarpila, E ;
Franzén, T ;
Berglund, J ;
Kullman, E ;
Franzén, L .
BRITISH JOURNAL OF SURGERY, 2000, 87 (05) :618-626
[5]   MAXIMUM LIKELIHOOD FROM INCOMPLETE DATA VIA EM ALGORITHM [J].
DEMPSTER, AP ;
LAIRD, NM ;
RUBIN, DB .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-METHODOLOGICAL, 1977, 39 (01) :1-38
[6]   A COMPARISON OF LINKAGE DISEQUILIBRIUM MEASURES FOR FINE-SCALE MAPPING [J].
DEVLIN, B ;
RISCH, N .
GENOMICS, 1995, 29 (02) :311-322
[7]   Hereditary diffuse gastric cancer [J].
Dunbier, A ;
Guilford, P .
ADVANCES IN CANCER RESEARCH, VOL 83, 2001, 83 :55-65
[8]  
FISHER RA, 1951, DESIGN EXPT, P1
[9]   E-cadherin germline mutations in familial gastric cancer [J].
Guilford, P ;
Hopkins, J ;
Harraway, J ;
McLeod, M ;
McLeod, N ;
Harawira, P ;
Taite, H ;
Scoular, R ;
Miller, A ;
Reeve, AE .
NATURE, 1998, 392 (6674) :402-405
[10]  
HOWSON CP, 1986, EPIDEMIOL REV, V8, P1